+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cannabis Pharmaceuticals Market by Product Type (Capsule, Oil, Patch), Compound Type (Cbd, Cbg, Cbn), Application, Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Cannabis Pharmaceuticals Market by Product Type (Capsule, Oil, Patch), Compound Type (Cbd, Cbg, Cbn), Application, Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Sale

Cannabis Pharmaceuticals Market by Product Type (Capsule, Oil, Patch), Compound Type (Cbd, Cbg, Cbn), Application, Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010641
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cannabis pharmaceuticals market is evolving rapidly as science, regulation, and patient needs reshape the industry. Senior executives face significant decisions surrounding innovation, compliance, and supply chain resilience in a sector experiencing unprecedented change.

Market Snapshot: Cannabis Pharmaceuticals Market Growth and Trajectory

The Cannabis Pharmaceuticals Market grew from USD 1.71 billion in 2024 to USD 2.04 billion in 2025. It is expected to continue growing at a CAGR of 18.80%, reaching USD 4.83 billion by 2030.

Scope & Segmentation

This report provides a robust assessment of the cannabis pharmaceuticals industry, analyzing emerging therapies, regulatory advancements, and operational strategies across global regions.

  • Product Types: Capsule (Hard Shell, Soft Gel), Oil (Broad Spectrum, Full Spectrum, Isolate), Patch, Tincture, Topical (Cream, Lotion, Salve)
  • Compound Types: Cannabidiol (CBD), Cannabigerol (CBG), Cannabinol (CBN), Tetrahydrocannabinol (THC)
  • Applications: Dermatology, Neurological Disorders, Oncology Support, Pain Management
  • Routes of Administration: Inhalation, Oral, Sublingual, Topical
  • Distribution Channels: Direct to Patient Sales, Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
  • End Users: Clinics, Homecare, Hospitals, Specialized Centers
  • Regional Coverage: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)

Technologies such as precision medicine, digital therapeutics, advanced extraction (supercritical CO2), and real-world data platforms also shape product development and patient engagement strategies.

Key Takeaways for Senior Decision-Makers

  • Innovative formulations and manufacturing techniques are enabling pharmaceutical companies to meet expanding therapeutic indications and regulatory demands.
  • The move towards patient-centric care is fostering tailored cannabinoid therapies, with multidisciplinary teams managing complex conditions and comorbidities.
  • Increasing collaboration—through strategic partnerships, joint ventures, and mergers—accelerates clinical validation, scales production, and broadens market access for leading companies.
  • Precision medicine and digital health integration offer robust real-world evidence, supporting regulatory submissions and value-based pricing.
  • Regional regulatory divergence compels localized strategies, as market dynamics differ substantially across Americas, EMEA, and Asia-Pacific.

Tariff Impact: Navigating U.S. Tariff Adjustments

Recent U.S. tariff changes have driven manufacturers to reconsider supply chain logistics, prioritizing domestic cultivation and processing to mitigate exposure. Companies increasingly invest in vertical integration, form strategic alliances, and seek tariff exclusions through international trade mechanisms. These shifts impact operational efficiency and pricing, requiring a proactive approach to cost management and access strategies. Payers now link reimbursement to clinical outcomes, further influencing contract negotiations and product positioning across global markets.

Methodology & Data Sources

This report relies on primary research from interviews with industry leaders, clinical experts, and regulatory authorities. Secondary data comes from peer-reviewed journals, corporate disclosures, and financial databases. Rigorous data triangulation ensures accuracy, and findings have been validated through stakeholder review and systematic cross-referencing.

Why This Report Matters

  • Senior executives will recognize actionable strategies to enhance supply chain resilience, product innovation, and competitive differentiation.
  • The report equips decision-makers to navigate complex policy environments, anticipate reimbursement changes, and engage in informed market entry or expansion planning.
  • Comprehensive segmentation and global insights help leaders benchmark their organizations and align strategic initiatives with key market drivers.

Cannabis Pharmaceuticals Market: Leading Companies

  • Jazz Pharmaceuticals plc
  • Canopy Growth Corporation
  • Tilray Brands, Inc.
  • Aurora Cannabis Inc.
  • Cronos Group Inc.
  • Curaleaf Holdings, Inc.
  • Trulieve Cannabis Corp.
  • Organigram Holdings Inc.
  • MediPharm Labs Corp.
  • Avicanna Inc.

Conclusion

The cannabis pharmaceuticals market is propelled by evolving science, technology, and regulation. Leaders who invest in innovation, operational agility, and data-driven strategy will be equipped to thrive as the market matures and new opportunities arise.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of pharmaceutically standardized CBD products in pediatric epilepsy treatment protocols
5.2. Expansion of cannabinoid-based immunotherapy research for autoimmune disease management
5.3. Integration of synthetic THC analogues into targeted chemotherapy adjunctive care regimens
5.4. Emergence of personalized cannabinoid formulations guided by pharmacogenomic patient profiling
5.5. Regulatory harmonization efforts for cross-border clinical trials in cannabis-derived pharmaceuticals
5.6. Development of novel cannabinoid nanoparticle delivery systems to enhance blood-brain barrier penetration
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cannabis Pharmaceuticals Market, by Product Type
8.1. Introduction
8.2. Capsule
8.2.1. Hard Shell
8.2.2. Soft Gel
8.3. Oil
8.3.1. Broad Spectrum
8.3.2. Full Spectrum
8.3.3. Isolate
8.4. Patch
8.5. Tincture
8.6. Topical
8.6.1. Cream
8.6.2. Lotion
8.6.3. Salve
9. Cannabis Pharmaceuticals Market, by Compound Type
9.1. Introduction
9.2. Cbd
9.3. Cbg
9.4. Cbn
9.5. Thc
10. Cannabis Pharmaceuticals Market, by Application
10.1. Introduction
10.2. Dermatology
10.3. Neurological Disorders
10.4. Oncology Support
10.5. Pain Management
11. Cannabis Pharmaceuticals Market, by Route Of Administration
11.1. Introduction
11.2. Inhalation
11.3. Oral
11.4. Sublingual
11.5. Topical
12. Cannabis Pharmaceuticals Market, by Distribution Channel
12.1. Introduction
12.2. Direct To Patient Sales
12.3. Hospital Pharmacies
12.4. Online Pharmacies
12.5. Retail Pharmacies
13. Cannabis Pharmaceuticals Market, by End User
13.1. Introduction
13.2. Clinics
13.3. Homecare
13.4. Hospitals
13.5. Specialized Centers
14. Americas Cannabis Pharmaceuticals Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Cannabis Pharmaceuticals Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Cannabis Pharmaceuticals Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Jazz Pharmaceuticals plc
17.3.2. Canopy Growth Corporation
17.3.3. Tilray Brands, Inc.
17.3.4. Aurora Cannabis Inc.
17.3.5. Cronos Group Inc.
17.3.6. Curaleaf Holdings, Inc.
17.3.7. Trulieve Cannabis Corp.
17.3.8. Organigram Holdings Inc.
17.3.9. MediPharm Labs Corp.
17.3.10. Avicanna Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CANNABIS PHARMACEUTICALS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CANNABIS PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CANNABIS PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. CANNABIS PHARMACEUTICALS MARKET: RESEARCHAI
FIGURE 28. CANNABIS PHARMACEUTICALS MARKET: RESEARCHSTATISTICS
FIGURE 29. CANNABIS PHARMACEUTICALS MARKET: RESEARCHCONTACTS
FIGURE 30. CANNABIS PHARMACEUTICALS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CANNABIS PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HARD SHELL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HARD SHELL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SOFT GEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SOFT GEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BROAD SPECTRUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BROAD SPECTRUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY FULL SPECTRUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY FULL SPECTRUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ISOLATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ISOLATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TINCTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TINCTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY LOTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY LOTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SALVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SALVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CBD, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CBD, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CBG, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CBG, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CBN, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CBN, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY THC, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY THC, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONCOLOGY SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONCOLOGY SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SUBLINGUAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SUBLINGUAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DIRECT TO PATIENT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DIRECT TO PATIENT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SPECIALIZED CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SPECIALIZED CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 133. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 136. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 137. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2024 (USD MILLION)
TABLE 138. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2025-2030 (USD MILLION)
TABLE 139. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 140. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 141. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
TABLE 142. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2025-2030 (USD MILLION)
TABLE 143. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 146. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 147. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2024 (USD MILLION)
TABLE 156. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2025-2030 (USD MILLION)
TABLE 157. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 158. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 159. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
TABLE 160. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2025-2030 (USD MILLION)
TABLE 161. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 162. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 163. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 164. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 165. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 246. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 247. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2024 (USD MILLION)
TABLE 248. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2025-2030 (USD MILLION)
TABLE 249. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 250. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 251. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
TABLE 252. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2025-2030 (USD MILLION)
TABLE 253. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 256. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 257. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 264. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 265. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2024 (USD MILLION)
TABLE 266. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2025-2030 (USD MILLION)
TABLE 267. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 268. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 269. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
TABLE 270. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2025-2030 (USD MILLION)
TABLE 271. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 274. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 275. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 298. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 299. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 300. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 301. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2024 (USD MILLION)
TABLE 302. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2025-2030 (USD MILLION)
TABLE 303. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 304. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 305. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
TABLE 306. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2025-2030 (USD MILLION)
TABLE 307. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 308. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 309. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 310. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 311. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 316. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 317. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 318. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 319. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2024 (USD MILLION)
TABLE 320. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2025-2030 (USD MILLION)
TABLE 321. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 322. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 323. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
TABLE 324. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2025-2030 (USD MILLION)
TABLE 325. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 326. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 327. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 328. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY

Samples

Loading
LOADING...

Companies Mentioned

  • Jazz Pharmaceuticals plc
  • Canopy Growth Corporation
  • Tilray Brands, Inc.
  • Aurora Cannabis Inc.
  • Cronos Group Inc.
  • Curaleaf Holdings, Inc.
  • Trulieve Cannabis Corp.
  • Organigram Holdings Inc.
  • MediPharm Labs Corp.
  • Avicanna Inc.

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.04 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.83 Billion
Compound Annual Growth Rate18.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Cannabis Extraction Market by Extraction Method (Co2 Supercritical, Ethanol, Hydrocarbon), Product Type (Capsules, Crumble, Distillate), End Use, Equipment Type, Compound Type, Form - Global Forecast 2025-2030 - Product Image

Cannabis Extraction Market by Extraction Method (Co2 Supercritical, Ethanol, Hydrocarbon), Product Type (Capsules, Crumble, Distillate), End Use, Equipment Type, Compound Type, Form - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Medical Cannabis Market Report 2025-2033 - Product Image

Medical Cannabis Market Report 2025-2033

  • Report
  • 125 Pages
  • Global
From
Cannabis Extract Market by Product Type (Butane Hash Oil, Co2 Oil, Distillate), Purity Grade (Broad-Spectrum, Full-Spectrum, Isolate), Form, Extraction Method, Cannabinoid Type, Packaging Type, Application, Distribution Channel - Global Forecast 2025-2030 - Product Image

Cannabis Extract Market by Product Type (Butane Hash Oil, Co2 Oil, Distillate), Purity Grade (Broad-Spectrum, Full-Spectrum, Isolate), Form, Extraction Method, Cannabinoid Type, Packaging Type, Application, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Cannabis Market by Compound Type, Product Type, Application, Source, and Region - Global Forecast to 2030 - Product Image

Cannabis Market by Compound Type, Product Type, Application, Source, and Region - Global Forecast to 2030

  • Report
  • 325 Pages
  • Global
From
Cannabis Pharmaceuticals Market Report 2025 - Product Image

Cannabis Pharmaceuticals Market Report 2025

  • Report
  • 175 Pages
  • Global
From

About the Cannabis Pharmaceuticals Market

The Cannabis Pharmaceuticals market within the context of Analgesics is a rapidly growing sector of the pharmaceutical industry. Cannabis-based pharmaceuticals are used to treat a variety of conditions, including chronic pain, inflammation, and neurological disorders. These drugs are often used in combination with traditional analgesics to provide a more comprehensive approach to pain management. Cannabis-based pharmaceuticals are also being studied for their potential to reduce opioid dependence and addiction. Cannabis-based pharmaceuticals are available in a variety of forms, including oral capsules, topical creams, and sublingual sprays. These products are often formulated with other active ingredients, such as cannabinoids, terpenes, and flavonoids, to provide additional therapeutic benefits. Several companies are currently operating in the Cannabis Pharmaceuticals market, including GW Pharmaceuticals, Tilray, and Zynerba Pharmaceuticals. These companies are focused on developing and commercializing cannabis-based pharmaceuticals for the treatment of various conditions. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.